Striatal genes regulated by super-enhancers and displaying low paused RNAPII are preferentially down-regulated in Huntington's disease
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA255648 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:Huntington neurodegenerative disease (HD) is associated with extensive down-regulation of neuronal genes. We show preferential down-regulation of super-enhancer-regulated neuronal function genes in the striatum of HD mice. Striatal super-enhancers display extensive H3K27 acetylation within gene bodies and drive transcription characterized by low levels of paused RNAPII. Down-regulation of gene expression is associated with diminished H3K27 acetylation and RNAPII recruitment. Striatal super-enhancers are enriched in binding motifs for Gata transcription factors, such as Gata2 regulating striatal identity genes. Thus, enhancer topography and transcription dynamics are major parameters determining the propensity of a gene to be deregulated in a neurodegenerative disease. Examination of H3k27ac and RNA pol II in Striatum by deep sequencing
2015-04-01 | E-GEOD-59570 | biostudies-arrayexpress
Project description:Huntington neurodegenerative disease (HD) is associated with extensive down-regulation of neuronal genes. We show preferential down-regulation of super-enhancer-regulated neuronal function genes in the striatum of HD mice. Striatal super-enhancers display extensive H3K27 acetylation within gene bodies and drive transcription characterized by low levels of paused RNAPII. Down-regulation of gene expression is associated with diminished H3K27 acetylation and RNAPII recruitment. Striatal super-enhancers are enriched in binding motifs for Gata transcription factors, such as Gata2 regulating striatal identity genes. Thus, enhancer topography and transcription dynamics are major parameters determining the propensity of a gene to be deregulated in a neurodegenerative disease. RNA profiles in Striatum of WT and R6/1 mice by deep sequencing using Illumina HiSeq 2000.
2015-04-01 | E-GEOD-59571 | biostudies-arrayexpress
Project description:Huntington neurodegenerative disease (HD) is associated with extensive down-regulation of neuronal genes. We show preferential down-regulation of super-enhancer-regulated neuronal function genes in the striatum of HD mice. Striatal super-enhancers display extensive H3K27 acetylation within gene bodies and drive transcription characterized by low levels of paused RNAPII. Down-regulation of gene expression is associated with diminished H3K27 acetylation and RNAPII recruitment. Striatal super-enhancers are enriched in binding motifs for Gata transcription factors, such as Gata2 regulating striatal identity genes. Thus, enhancer topography and transcription dynamics are major parameters determining the propensity of a gene to be deregulated in a neurodegenerative disease.
2015-04-01 | GSE59571 | GEO
Project description:Huntington neurodegenerative disease (HD) is associated with extensive down-regulation of neuronal genes. We show preferential down-regulation of super-enhancer-regulated neuronal function genes in the striatum of HD mice. Striatal super-enhancers display extensive H3K27 acetylation within gene bodies and drive transcription characterized by low levels of paused RNAPII. Down-regulation of gene expression is associated with diminished H3K27 acetylation and RNAPII recruitment. Striatal super-enhancers are enriched in binding motifs for Gata transcription factors, such as Gata2 regulating striatal identity genes. Thus, enhancer topography and transcription dynamics are major parameters determining the propensity of a gene to be deregulated in a neurodegenerative disease.
2015-04-01 | GSE59570 | GEO
Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series
2015-04-01 | E-GEOD-59572 | biostudies-arrayexpress
Project description:This SuperSeries is composed of the SubSeries listed below.
2015-04-01 | GSE59572 | GEO
Project description:Transcription by RNA Polymerase II (Pol II) in metazoan is regulated in several steps, including preinitiation complex (PIC) formation, initiation, Pol II escape, productive elongation, cotranscriptional RNA-processing and termination. Genome-wide studies have demonstrated that the phenomenon of promoter-bound Pol II pausing is widespread, especially for genes involved in developmental and stimulus-responsive pathways. However, a mechanistic understanding of the paused Pol II states at promoters is limited. For example, at a global level, it’s unclear to what extent the engaged paused Pol II is stably tethered to the promoter or undergoes rapid cycles of initiation and termination. Here we used the small molecule Triptolide (TPL), an XPB/TFIIH inhibitor, to block transcriptional initiation followed by measuring Pol II occupancy by ChIP-seq. This inhibition of initiation enables us to investigate different states of paused Pol II. Specifically, our global analysis reveals that most genes with paused Pol II, as defined by pausing index, show significant clearance of Pol II during the period of TPL treatment. Our study further identifies a group of genes with unexpectedly stably-paused Pol II, with unchanged Pol II occupancy even after one hour of inhibition of initiation. This group of genes constitutes a small portion of all paused genes defined by the conventional criterion of pausing index. These findings could pave the way for evaluating the contribution of different elongation/pausing factors on different states of Pol II pausing in developmental and other stimulus-responsive pathways. ChIP-Seq of total/Ser5P Pol II in HCT116 cells treated with DMSO or TPL in serum starvation/activation or normal conditions. Nascent RNA-seq in HCT116 cells treated with DMSO or TPL in starved condition.
2015-01-05 | E-GEOD-63314 | biostudies-arrayexpress
Project description:Low Klf4 expression reproducibly gives rise to a homogeneous population of partially reprogrammed iPSCs. Upregulation of Klf4 allows these cells to resume reprogramming, indicating that they are paused iPSCs that remain on the path towards pluripotency. Paused iPSCs with different Klf4 expression levels remain at distinct intermediate stages of reprogramming.
2015-03-23 | GSE56406 | GEO
Project description:Development is often assumed to be a sequential unfolding of genetic programs towards increased complexity and occurring with a very stereotypical timing. However, embryos across all lineages of metazoans can enter reversible states of developmental pausing in response to adverse environmental conditions. In mammals, pausing manifests as a delayed implantation of the blastocyst, the source of embryonic stem cells (ESCs). Paused pluripotency can be induced in mouse blastocysts and ESCs by inhibition of mTOR, a conserved growth-promoting kinase, and is characterized by a drastic global decrease in biosynthetic activity, including gene transcription. The molecular mechanisms by which this remarkable dormant cellular state is achieved remain largely unknown. Here we show that m6A RNA methylation by Mettl3 is essential for transcriptional dormancy and maintenance of the paused pluripotent state in vitro and in vivo. Mass spectrometry and transcriptome-wide sequencing revealed an increase in m6A in paused ESCs. Knockout of the RNA methyltransferase Mettl3 suppresses transcriptional and proliferation dormancy of ESC specifically in the paused state, and leads to loss of paused blastocysts. Integration of several datasets in vitro and in vivo identified the transcriptional amplifier and oncogene Mycn as a key “anti-pausing factor” regulated by m6A mRNA methylation. Mett3-mediated methylation at a specific site of the Mycn mRNA is essential for its destabilization, which in turns mediates suppression of nascent transcription and proliferation in paused conditions. Our results highlight an intricate feedback between signaling, regulation of RNA stability and nascent transcription during pausing, with Mettl3 as an essential integrator and Mycn as a key downstream anti-pausing factor. These findings shed light on the mechanisms that underlie tuning of global transcriptional output during mammalian developmental pausing, and that may be redeployed in adult stem cells or during cancer dormancy.
2023-05-19 | GSE228733 | GEO
Project description:Development is often assumed to be a sequential unfolding of genetic programs towards increased complexity and occurring with a very stereotypical timing. However, embryos across all lineages of metazoans can enter reversible states of developmental pausing in response to adverse environmental conditions. In mammals, pausing manifests as a delayed implantation of the blastocyst, the source of embryonic stem cells (ESCs). Paused pluripotency can be induced in mouse blastocysts and ESCs by inhibition of mTOR, a conserved growth-promoting kinase, and is characterized by a drastic global decrease in biosynthetic activity, including gene transcription. The molecular mechanisms by which this remarkable dormant cellular state is achieved remain largely unknown. Here we show that m6A RNA methylation by Mettl3 is essential for transcriptional dormancy and maintenance of the paused pluripotent state in vitro and in vivo. Mass spectrometry and transcriptome-wide sequencing revealed an increase in m6A in paused ESCs. Knockout of the RNA methyltransferase Mettl3 suppresses transcriptional and proliferation dormancy of ESC specifically in the paused state, and leads to loss of paused blastocysts. Integration of several datasets in vitro and in vivo identified the transcriptional amplifier and oncogene Mycn as a key “anti-pausing factor” regulated by m6A mRNA methylation. Mett3-mediated methylation at a specific site of the Mycn mRNA is essential for its destabilization, which in turns mediates suppression of nascent transcription and proliferation in paused conditions. Our results highlight an intricate feedback between signaling, regulation of RNA stability and nascent transcription during pausing, with Mettl3 as an essential integrator and Mycn as a key downstream anti-pausing factor. These findings shed light on the mechanisms that underlie tuning of global transcriptional output during mammalian developmental pausing, and that may be redeployed in adult stem cells or during cancer dormancy.
2023-05-19 | GSE202847 | GEO